查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566866

顱內壓 (ICP) 監測市場：按技術、按應用、按最終用戶：2024-2033 年全球機會分析和產業預測

Intracranial Pressure Monitoring Market By Technique, By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 216 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

顱內壓 (ICP) 監測市場

2023年顱內壓（ICP）監測市值為4億美元，預計2024年至2033年複合年成長率為5.1%，到2033年將達6億美元。

ICP 監測是一種診斷測試，可測量顱腔內某些液體（例如腦脊髓液或血液）產生的顱內壓。將導管或感測器插入大腦中的腦脊髓液空間以測量壓力。進行 ICP 監測對於多種醫療狀況至關重要，包括中風、創傷性腦損傷、腦腫瘤和神經系統疾病。透過 ICP 監測，醫療保健提供者可以評估腦損傷的強度，識別顱內動態的變化，並做出治療決策。

由於技術的不斷進步，ICP監測有效性的快速提高是市場的主要促進因素。無線連接、感測器小型化以及與數位健康平台的整合使醫療保健提供者能夠收集即時資料、做出明智的決策並改善神經關鍵環境中的患者照護。未來，非侵入性ICP監測有望成為醫療保健領域的主流。目前正在快速進行研究和開發工作，以減輕現有非侵入性手術的局限性，例如經顱都蔔勒超音波超音波、腦組織共振和靜脈血壓計。

然而，最尖端科技的進步導致診斷測試變得更加昂貴，並且對許多人來說遙不可及。此外，採購ICP監測相關設備的初始成本較高，加上校準、維護和耗材成本，使得中小型醫療機構難以投資。相反，人工智慧的引入是一個創新領域，有望為顱內壓（ICP）監測市場開闢新途徑。人工智慧有望分析設備產生的大型資料集，並識別人類觀察可能跳過的異常情況。人工智慧預測模型提供的提案預計將支援按時提供醫療回應，從而改善患者的治療結果。

分部審查

顱內壓 (ICP) 監測市場分為技術、應用、最終用戶和地區。依手術方式分為侵入式和非侵入式。依用途分為腦外傷、腦出血、腦膜炎等。依最終用戶分類，可分為醫院、診所、私人醫療機構、創傷中心和政府/研究機構。從區域來看，我們對北美、歐洲、亞太地區和拉丁美洲地區進行了分析。

主要發現

以手術方式來看，2023 年非侵入式手術的收益最高。

從應用來看，創傷性腦損傷細分市場在 2023 年的收益最高。

從最終用戶來看，醫院細分市場將在 2023 年獲得更高的市場佔有率。

可以自訂此報告（需要額外的費用和時間表）

  • 監管指引
  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 公司簡介的擴充列表
  • 歷史市場資料

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 主要投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章顱內壓（ICP）監測市場：依技術分類

  • 市場概況
  • 侵入性的
  • 非侵入性

第5章顱內壓（ICP）監測市場：依應用分類

  • 市場概況
  • 腦外傷
  • 腦出血
  • 腦膜炎
  • 其他

第6章顱內壓 (ICP) 監測市場：依最終使用者分類

  • 市場概況
  • 醫院
  • 診所
  • 私人診所
  • 創傷中心
  • 政府機構和研究機構

第7章顱內壓（ICP）監測市場：依地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國顱內壓（ICP）監測市場
    • 加拿大顱內壓（ICP）監測市場
    • 墨西哥顱內壓（ICP）監測市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 法國顱內壓（ICP）監測市場
    • 德國顱內壓（ICP）監測市場
    • 義大利顱內壓（ICP）監測市場
    • 西班牙顱內壓（ICP）監測市場
    • 英國顱內壓（ICP）監測市場
    • 其他歐洲國家顱內壓 (ICP) 監測市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 中國顱內壓（ICP）監測市場
    • 日本顱內壓（ICP）監測市場
    • 印度顱內壓（ICP）監測市場
    • 韓國顱內壓（ICP）監測市場
    • 澳洲顱內壓（ICP）監測市場
    • 其他亞太地區顱內壓 (ICP) 監測市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西顱內壓（ICP）監測市場
    • 南非顱內壓（ICP）監測市場
    • 沙烏地阿拉伯顱內壓（ICP）監測市場
    • 其他拉丁美洲/中東/非洲顱內壓 (ICP) 監測市場

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第9章 公司簡介

  • BrainLAB
  • Natus Medical Incorporated
  • Integra LifeSciences
  • GE Healthcare
  • Teleflex Incorporated
  • Sick AG
  • Smiths Medical
  • Koninklijke Philips NV
  • Elekta AB
  • AMETEK
簡介目錄
Product Code: A149770

Intracranial Pressure (ICP) Monitoring Market

The intracranial pressure (ICP) monitoring market was valued at $0.4 billion in 2023, and is projected to reach $0.6 billion by 2033, growing at a CAGR of 5.1% from 2024 to 2033.

ICP monitoring is a diagnostic test for measuring the pressure inside the skull, exerted by certain fluids such as cerebrospinal fluid and blood within the cranial cavity. A catheter or sensor is inserted into the cerebrospinal fluid space of brain in this procedure to gauge the pressure. Conducting ICP monitoring is pivotal in various medical conditions, including stroke, traumatic brain injury, brain tumors, and neurological disorders. Healthcare providers assess the intensity of brain injury through ICP monitoring, identify modifications in intracranial dynamics, and make treatment decisions.

Surge in the efficacy of ICP monitoring due to continuous technological advancements is a major driver of the market. Wireless connectivity, miniaturization of sensors, and assimilation with digital health platforms have enabled healthcare providers to garner real-time data, make well-informed decisions, and elevate patient care in neurocritical settings. In future, the trend of non-invasive ICP monitoring is projected to dominate in the healthcare settings. Currently, R&D efforts are in full pace to mitigate the limitations of existing non-invasive procedures such as transcranial doppler ultrasonography, brain tissue resonance, and venous ophthalmodynamometry.

However, cutting-edge technological advancements result in high cost of diagnostic tests, making it unaffordable for several individuals. Moreover, the high initial cost of procuring equipment associated with ICP monitoring; along with calibration, maintenance, and consumable expenses; makes it challenging for several small & medium-sized healthcare facilities to invest in them. On the contrary, the deployment of AI is a field of innovation expected to open new avenues for the intracranial pressure (ICP) monitoring market. AI is anticipated to analyze large datasets generated from the equipment and identify the abnormalities that are possible skippable by human observation. Suggestions offered by predictive model of AI are projected to aid in on-time delivery of medical responses, hence improving patient outcomes.

Segment Review

The intracranial pressure (ICP) monitoring market is segmented into technique, application, end user, and region. On the basis of technique, the market is bifurcated into invasive and non-invasive. By application, it is divided into traumatic brain injury, intracerebral hemorrhage, meningitis, and others. Depending on end user, it is classified into hospital, clinics, private medical offices, trauma centers, and government & research organizations. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of technique, the non-invasive segment generated the highest revenue in the market in 2023.

By application, the traumatic brain injury segment was the highest revenue generator in 2023

Depending on end user, the hospital segment acquired higher stakes of the market in 2023.

Competition Analysis

The major players operating in the global intracranial pressure (ICP) monitoring market include BrainLAB, Natus Medical Incorporated, Integra LifeSciences, GE Healthcare, Teleflex Incorporated, Sick AG, Smiths Medical, Koninklijke Philips N.V, Elekta AB, and AMETEK. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Technique

  • Invasive
  • Non-Invasive

By Application

  • Traumatic Brain Injury
  • Intracerebral Hemorrhage
  • Meningitis
  • Others

By End User

  • Hospital
  • Clinics
  • Private Medical Offices
  • Trauma Centers
  • Government and Research Organizations

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • BrainLAB
    • Natus Medical Incorporated
    • Integra LifeSciences
    • GE Healthcare
    • Teleflex Incorporated
    • Sick AG
    • Smiths Medical
    • Koninklijke Philips N.V
    • Elekta AB
    • AMETEK

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.5. Market Dynamics
    • 3.5.1. Drivers
    • 3.5.2. Restraints
    • 3.5.3. Opportunities

CHAPTER 4: INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Technique
  • 4.2. Invasive
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Non-Invasive
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Traumatic Brain Injury
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Intracerebral Hemorrhage
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Meningitis
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospital
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Clinics
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Private Medical offices
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Trauma Centers
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country
  • 6.6. Government And Research Organizations
    • 6.6.1. Key Market Trends, Growth Factors and Opportunities
    • 6.6.2. Market Size and Forecast, By Region
    • 6.6.3. Market Share Analysis, By Country

CHAPTER 7: INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Technique
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Intracranial Pressure (ICP) Monitoring Market
      • 7.2.6.1. Market Size and Forecast, By Technique
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Intracranial Pressure (ICP) Monitoring Market
      • 7.2.7.1. Market Size and Forecast, By Technique
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Intracranial Pressure (ICP) Monitoring Market
      • 7.2.8.1. Market Size and Forecast, By Technique
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Technique
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Intracranial Pressure (ICP) Monitoring Market
      • 7.3.6.1. Market Size and Forecast, By Technique
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Intracranial Pressure (ICP) Monitoring Market
      • 7.3.7.1. Market Size and Forecast, By Technique
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Intracranial Pressure (ICP) Monitoring Market
      • 7.3.8.1. Market Size and Forecast, By Technique
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Intracranial Pressure (ICP) Monitoring Market
      • 7.3.9.1. Market Size and Forecast, By Technique
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Intracranial Pressure (ICP) Monitoring Market
      • 7.3.10.1. Market Size and Forecast, By Technique
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Intracranial Pressure (ICP) Monitoring Market
      • 7.3.11.1. Market Size and Forecast, By Technique
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Technique
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Intracranial Pressure (ICP) Monitoring Market
      • 7.4.6.1. Market Size and Forecast, By Technique
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Intracranial Pressure (ICP) Monitoring Market
      • 7.4.7.1. Market Size and Forecast, By Technique
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Intracranial Pressure (ICP) Monitoring Market
      • 7.4.8.1. Market Size and Forecast, By Technique
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Intracranial Pressure (ICP) Monitoring Market
      • 7.4.9.1. Market Size and Forecast, By Technique
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Intracranial Pressure (ICP) Monitoring Market
      • 7.4.10.1. Market Size and Forecast, By Technique
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Intracranial Pressure (ICP) Monitoring Market
      • 7.4.11.1. Market Size and Forecast, By Technique
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Technique
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Intracranial Pressure (ICP) Monitoring Market
      • 7.5.6.1. Market Size and Forecast, By Technique
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Intracranial Pressure (ICP) Monitoring Market
      • 7.5.7.1. Market Size and Forecast, By Technique
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Intracranial Pressure (ICP) Monitoring Market
      • 7.5.8.1. Market Size and Forecast, By Technique
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Intracranial Pressure (ICP) Monitoring Market
      • 7.5.9.1. Market Size and Forecast, By Technique
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. BrainLAB
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Natus Medical Incorporated
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Integra LifeSciences
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. GE Healthcare
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Teleflex Incorporated
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Sick AG
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Smiths Medical
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Koninklijke Philips N.V
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Elekta AB
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. AMETEK
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments